Study Evaluating Premarin and Bazedoxifene Potential Interaction
Status:
Completed
Trial end date:
2008-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the pharmacokinetics (absorption, distribution,
breakdown and elimination in the body) of a single dose of bazedoxifene (BZA) 20 mg tablet
when administered together with multiple doses of Premarin (conjugated estrogens or CE) to
healthy postmenopausal women.
Information will also be obtained regarding the safety and tolerability of this combination
in healthy, postmenopausal women.